Zimmer Biomet Holdings, Inc. (VIE:ZBH)

Market Cap	15.24B -26.2%
Revenue (ttm)	7.01B +7.2%
Net Income	600.53M -22.0%
EPS	3.02 -19.9%
Shares Out	n/a
PE Ratio	25.38
Forward PE	10.71
Dividend	0.82 (1.05%)
Ex-Dividend Date	Mar 31, 2026

Volume	n/a
Average Volume	5
Open	78.48
Previous Close	78.18
Day's Range	78.30 - 78.84
52-Week Range	71.50 - 104.10
Beta	n/a
RSI	50.29
Earnings Date	May 6, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well a...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ZBH

Financial Performance

In 2025, Zimmer Biomet Holdings's revenue was $8.23 billion, an increase of 7.20% compared to the previous year's $7.68 billion. Earnings were $705.10 million, a decrease of -21.98%.

Financial numbers in USD